{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:27:55Z","timestamp":1770348475370,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":4947,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1053\/rmed.1999.0678","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:08Z","timestamp":1032432908000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the EasibreatheTMinhaler for the treatment of paediatric asthma"],"prefix":"10.1053","volume":"94","author":[{"given":"I.S.","family":"FARMER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"MIDDLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"SAVIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.L.","family":"PERRIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"HERDMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/rmed.1999.0678_RF1","unstructured":"Command Paper no. 977; Treaty Series 1990 (19); Montreal Protocol, Substances that deplete the ozone layer, 16th September 1987"},{"key":"10.1053\/rmed.1999.0678_RF2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2165\/00003495-197510030-00002","article-title":"Beclomethasone Dipropionate inhaler: A review of its pharmacology, therapeutic values and adverse events","volume":"10","author":"Brogden","year":"1975","journal-title":"Drugs"},{"key":"10.1053\/rmed.1999.0678_RF3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1089\/jam.1995.8.Suppl_1.S-35","article-title":"Clinical Pharmacology of HFA-143a","volume":"8","author":"Ventresca","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1053\/rmed.1999.0678_RF4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.2042-7158.1996.tb05980.x","article-title":"Twenty-eight day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects","volume":"48","author":"Harrison","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1053\/rmed.1999.0678_RF5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00045391-199611000-00005","article-title":"Pharmacokinetics of HFA-134a: a preliminary report","volume":"3","author":"Harrison","year":"1996","journal-title":"Am J Therapeut"},{"key":"10.1053\/rmed.1999.0678_RF6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1742-1241.1997.tb09618.x","article-title":"Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate","volume":"51","author":"Dahl","year":"1997","journal-title":"Br J Clin Pract"},{"key":"10.1053\/rmed.1999.0678_RF7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0954-6111(98)90214-1","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chloroflurocarbon beclomethasone dipropionate at approximately half the total dose","volume":"92","author":"Davies","year":"1998","journal-title":"Respir Med"},{"key":"10.1053\/rmed.1999.0678_RF8","first-page":"133","article-title":"Enhanced drug delivery through reformulating MDIs with HFA propellants \u2014 drug deposition and its effect on preclinical and clinical programs","volume":"5","author":"Leach","year":"1996","journal-title":"Resp Drug Delivery"},{"key":"10.1053\/rmed.1999.0678_RF9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0954-6111(95)90085-3","article-title":"Determining equivalence of inhaled medications. Worshop report","volume":"89","author":"Rogers","year":"1995","journal-title":"Respir Med"},{"key":"10.1053\/rmed.1999.0678_RF10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1183\/09031936.98.11051194","article-title":"Comparative safety and efficacy of inhaled corticosteroids: Report of a Committee of the Canadian Thoracic Society","volume":"11","author":"Boulet","year":"1998","journal-title":"Eur Resp J"},{"key":"10.1053\/rmed.1999.0678_RF11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0954-6111(99)90020-3","article-title":"Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma","volume":"93","author":"Milanowski","year":"1999","journal-title":"Respir Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611199906789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611199906789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:01:20Z","timestamp":1760608880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611199906789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0954611199906789"],"URL":"https:\/\/doi.org\/10.1053\/rmed.1999.0678","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the EasibreatheTMinhaler for the treatment of paediatric asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/rmed.1999.0678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}